Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.

Yoshiko KawataKazunori NagasakaYoko MatsumotoKatsutoshi OdaMichihiro TanikawaKenbun SoneMayuyo Mori-UchinoTetsushi TsurugaTakahide ArimotoYutaka OsugaTomoyuki Fujii

Published in: International journal of clinical oncology (2018)

CART is useful for the therapeutic management of AOC patients with refractory massive ascites. Elevations of body temperature after CART may be avoided by the investigation of patients' peritoneal cytology before CART.

Keyphrases

cell free
circulating tumor
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
fine needle aspiration
patient reported